ESMO 2016: True burden of head and neck cancer underestimated (France)
by Gary Finnegan A nationwide study of head and neck cancers in France has revealed that the true burden of the disease is underestimated by at least one-third,… read more.
by Gary Finnegan A nationwide study of head and neck cancers in France has revealed that the true burden of the disease is underestimated by at least one-third,… read more.
by Gary Finnegan: A clear trend towards lighter drinking among young people is responsible for reversing years of rising alcohol intake, according to new research. Experts hope this… read more.
by Gary Finnegan: People seeking refuge and asylum in Germany are at higher risks of liver problems due to hepatitis B, according to experts.
by Gary Finnegan: New research from Denmark has identified the gene responsible for one quarter of all familial hypercholesterolemia which causes very high blood cholesterol. Familial hypercholesterolemia is… read more.
by Gary Finnegan: After years of increases, the rates of children who are overweight or obese are declining in Canada, according to new research in CMAJ (Canadian Medical Association Journal).
by Gary Finnegan: Eight new medicines have been approved by the European Medicines Agency at its summer meeting. The influential Committee for Medicinal Products for Human use (CHMP)… read more.
by Gary Finnegan: The European Medicines Agency (EMA) has restructured its staff in a bid to efficiently deal changing demand. The Agency faces the challenge of keeping up… read more.
by Gary Finnegan: Within hours of the UK’s vote to leave the European Union, at least half a dozen countries began to call for the European Medicines Agency… read more.
by Gary Finnegan: Six medicines, including two combination therapies for chronic hepatitis C, have been recommended for approval at the May meeting of the European Medicines Agency’s Committee for… read more.
by Gary Finnegan: The EU drug watchdog is reviewing the guidelines on first-in-human clinical trials in response to the tragic death of a participant in a trial in… read more.
by Gary Finnegan: Most successful applicants to the EU drug watchdog, the European Medicines Agency, have something in common: they seek scientific advice from the regulator when developing… read more.
by Gary Finnegan: Cholesterol levels – the most common risk factor for heart attacks – have decreased in northern Sweden over the last 20 years. Since medication only… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.